B cells in GVHD: friend or foe?

Blood

Volumn 115, Issue 12, 2010, Pages 2558-2559

  Davis, Joanne E ^a   Ritchie, David S ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; INTERLEUKIN 10; RITUXIMAB;

B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CELL STIMULATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 77950567107     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-11-254177     Document Type: Letter

References (9)

1. Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS. The role of B cells in the pathogenesis of graft-versus-host disease [review]. Blood. 2009;114(24):4919-4927.
2. Park-Min KH, Serbina NV, Yang W, et al. FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity. 2007;26(1):67-78. (Pubitemid 46127754)
3. Tha-In T, Metselaar HJ, Tilanus HW, et al. Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells. Blood. 2007;110(9):3253-3262. (Pubitemid 350106318)
4. Spisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion. 2006;46(1):55-65. (Pubitemid 43381785)
5. Gatza E, Rogers CE, Clouthier SG, et al. Extracorporeal photopheresis reverses experimental graft-versus host disease through regulatory T cells. Blood. 2008;112(4):1515-1521.
6. Knoechel B, Lohr J, Kahn E, Abbas AK. Cutting edge: the link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J Immunol. 2005;175(1):21-26. (Pubitemid 40884296)
7. Rowe V, Banovic T, MacDonald KP, et al. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood. 2006;108(7):2485-2492. (Pubitemid 44497537)
8. Markey KA, Banovic T, Kuns RD, et al. Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation. Blood. 2009;113(22):5644-5649.
9. Chen LC, Delgado JC, Jensen PE, Chen X. Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application. J Immunol. 2009;183(6):4094-4102.